glycine has been researched along with Chronic Kidney Failure in 53 studies
Excerpt | Relevance | Reference |
---|---|---|
"Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, was evaluated in a phase 1b study in patients with end-stage renal disease with anemia on hemodialysis." | 9.34 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients. ( Chou, J; Hemmerich, S; Neff, TB; Provenzano, R; Tumlin, J; Yu, KP; Zabaneh, R, 2020) |
" PK and adverse events (AEs) were assessed after a single 3 mg dose of ixazomib." | 6.82 | A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis. ( Badros, A; Berdeja, J; Chari, A; Gupta, N; Hanley, MJ; Harvey, RD; Hui, AM; Kukreti, V; Lipe, B; Qian, M; Venkatakrishnan, K; Yang, H; Zhang, X, 2016) |
"We evaluated the efficacy and safety of roxadustat versus epoetin alfa for the treatment of chronic kidney disease-related anemia in patients new to dialysis." | 5.41 | Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. ( Besarab, A; Bradley, C; Eremeeva, L; Eyassu, M; Korneyeva, S; Leong, R; Liu, CS; Neff, TB; Poole, L; Provenzano, R; Saha, G; Shutov, E; Szczech, L; Yu, KP, 2021) |
"Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, was evaluated in a phase 1b study in patients with end-stage renal disease with anemia on hemodialysis." | 5.34 | Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients. ( Chou, J; Hemmerich, S; Neff, TB; Provenzano, R; Tumlin, J; Yu, KP; Zabaneh, R, 2020) |
" PK and adverse events (AEs) were assessed after a single 3 mg dose of ixazomib." | 2.82 | A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis. ( Badros, A; Berdeja, J; Chari, A; Gupta, N; Hanley, MJ; Harvey, RD; Hui, AM; Kukreti, V; Lipe, B; Qian, M; Venkatakrishnan, K; Yang, H; Zhang, X, 2016) |
"Ximelagatran is an oral direct thrombin inhibitor currently in clinical development as an anticoagulant for the prevention and treatment of thromboembolic disease." | 2.71 | Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran. ( Attman, PO; Eriksson, UG; Fager, G; Frison, L; Johansson, S; Mulec, H; Samuelsson, O, 2003) |
"Type 1 primary hyperoxaluria is a genetic disorder caused by deficiency of the liver-specific peroxisomal enzyme alanine-glyoxylate aminotransferase." | 2.49 | Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria. ( Fillaus, JA; Plumb, TJ; Swee, ML, 2013) |
" The fact that the concentrations of neither GAA nor Arg changed significantly after the injection of 14C-Arg in either group suggested that the dosage of injected Arg is not sufficient to affect the transformation of Arg to GAA." | 1.29 | Study on impaired metabolism of guanidinoacetic acid in chronic renal failure rabbits with special reference to impaired conversion of arginine to guanidinoacetic acid. ( Kuroda, M, 1993) |
"Five patients with chronic renal failure taking a diet containing approximately 5 g N throughout were studied during two periods of 1 month each." | 1.26 | Metabolic studies with keto acid diets. ( Ell, S; Fynn, M; Halliday, D; Richards, P, 1978) |
"3 ml/min/kg), terminal half-life (148 min), and total volume of distribution (1." | 1.25 | Pharmacokinetics and metabolism of lidocaine in patients with renal failure. ( Atkinson, AJ; Collinsworth, KA; Harrison, DC; Perlroth, F; Strong, JM; Winkle, RA, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (50.94) | 18.7374 |
1990's | 11 (20.75) | 18.2507 |
2000's | 6 (11.32) | 29.6817 |
2010's | 5 (9.43) | 24.3611 |
2020's | 4 (7.55) | 2.80 |
Authors | Studies |
---|---|
Csiky, B | 1 |
Schömig, M | 1 |
Esposito, C | 1 |
Barratt, J | 1 |
Reusch, M | 1 |
Valluri, U | 1 |
Sulowicz, W | 1 |
Provenzano, R | 3 |
Tumlin, J | 1 |
Zabaneh, R | 1 |
Chou, J | 1 |
Hemmerich, S | 2 |
Neff, TB | 3 |
Yu, KP | 2 |
Shutov, E | 1 |
Eremeeva, L | 1 |
Korneyeva, S | 1 |
Poole, L | 2 |
Saha, G | 2 |
Bradley, C | 1 |
Eyassu, M | 1 |
Besarab, A | 2 |
Leong, R | 1 |
Liu, CS | 1 |
Szczech, L | 2 |
Wu, R | 1 |
Peng, Y | 1 |
Wish, JB | 1 |
Plumb, TJ | 1 |
Swee, ML | 1 |
Fillaus, JA | 1 |
Wright, S | 1 |
Dua, S | 1 |
Zeig, S | 1 |
Nguyen, P | 1 |
Saikali, KG | 1 |
Yu, KH | 1 |
Gupta, N | 1 |
Hanley, MJ | 1 |
Harvey, RD | 1 |
Badros, A | 1 |
Lipe, B | 1 |
Kukreti, V | 1 |
Berdeja, J | 1 |
Yang, H | 1 |
Hui, AM | 1 |
Qian, M | 1 |
Zhang, X | 1 |
Venkatakrishnan, K | 1 |
Chari, A | 1 |
Locatelli, F | 1 |
Fishbane, S | 1 |
Block, GA | 1 |
Macdougall, IC | 1 |
Hyndman, ME | 1 |
Manns, BJ | 1 |
Snyder, FF | 1 |
Bridge, PJ | 1 |
Scott-Douglas, NW | 1 |
Fung, E | 1 |
Parsons, HG | 1 |
Eriksson, UG | 2 |
Johansson, S | 1 |
Attman, PO | 2 |
Mulec, H | 1 |
Frison, L | 1 |
Fager, G | 2 |
Samuelsson, O | 2 |
Rothe, HM | 1 |
Shapiro, WB | 1 |
Sun, WY | 1 |
Chou, SY | 1 |
Ottosson, P | 1 |
Eriksson-Lepkowska, M | 1 |
Chu, Y | 1 |
Alwahdani, A | 1 |
Iida, S | 1 |
Lund, DD | 1 |
Faraci, FM | 1 |
Heistad, DD | 1 |
Robertz, GM | 1 |
Dengler, HJ | 1 |
Sterner, G | 2 |
Asp, NG | 1 |
Dahlqvist, A | 1 |
Denneberg, T | 2 |
Lindberg, T | 2 |
Mitch, WE | 1 |
Brusilow, S | 1 |
Gold, CH | 1 |
Viljoen, M | 1 |
Mzamane, DV | 1 |
Mikami, H | 1 |
Orita, Y | 1 |
Ando, A | 1 |
Fujii, M | 1 |
Kikuchi, T | 1 |
Yoshihara, K | 1 |
Okada, A | 1 |
Abe, H | 1 |
Ochiai, Y | 1 |
Abe, S | 1 |
Yamada, T | 1 |
Tada, K | 1 |
Kosaka, F | 1 |
Levillain, O | 2 |
Marescau, B | 2 |
de Deyn, PP | 2 |
Garibotto, G | 1 |
Deferrari, G | 1 |
Robaudo, C | 1 |
Saffioti, S | 1 |
Sofia, A | 1 |
Russo, R | 1 |
Tizianello, A | 1 |
Lever, M | 1 |
Sizeland, PC | 1 |
Bason, LM | 1 |
Hayman, CM | 1 |
Robson, RA | 1 |
Chambers, ST | 1 |
Geissler, A | 1 |
Fründ, R | 1 |
Kohler, S | 1 |
Eichhorn, HM | 1 |
Krämer, BK | 1 |
Feuerbach, S | 1 |
Kuroda, M | 1 |
Renieri, A | 1 |
Bruttini, M | 1 |
Galli, L | 1 |
Zanelli, P | 1 |
Neri, T | 1 |
Rossetti, S | 1 |
Turco, A | 1 |
Heiskari, N | 1 |
Zhou, J | 1 |
Gusmano, R | 1 |
Massella, L | 1 |
Banfi, G | 1 |
Scolari, F | 1 |
Sessa, A | 1 |
Rizzoni, G | 1 |
Tryggvason, K | 1 |
Pignatti, PF | 1 |
Savi, M | 1 |
Ballabio, A | 1 |
De Marchi, M | 1 |
Guth, HJ | 1 |
Wiersbitzky, M | 1 |
Ziesche, M | 1 |
Rose, HJ | 1 |
Kraatz, G | 1 |
Ishihara, T | 1 |
Yokota, N | 1 |
Hisanaga, S | 1 |
Fujimoto, S | 1 |
Hirayama, N | 1 |
Kato, J | 1 |
Kitamura, K | 1 |
Eto, T | 1 |
Possemiers, I | 1 |
Al Banchaabouchi, M | 1 |
Ell, S | 1 |
Fynn, M | 1 |
Richards, P | 2 |
Halliday, D | 1 |
Bosseckert, H | 1 |
Collinsworth, KA | 1 |
Strong, JM | 1 |
Atkinson, AJ | 1 |
Winkle, RA | 1 |
Perlroth, F | 1 |
Harrison, DC | 1 |
Yokozawa, T | 1 |
Fujitsuka, N | 1 |
Oura, H | 1 |
Macpherson, NA | 1 |
Moscarello, MA | 1 |
Goldberg, DM | 1 |
Ish-Shalom, N | 1 |
Arbus, GS | 1 |
Druml, W | 1 |
Lochs, H | 1 |
Roth, E | 1 |
Hübl, W | 1 |
Balcke, P | 1 |
Lenz, K | 1 |
Jiang, J | 1 |
Wigger, M | 1 |
Stolpe, HJ | 1 |
Heine, W | 1 |
Wutzke, K | 1 |
Töwe, J | 1 |
Lumlertgul, D | 1 |
Burke, TJ | 1 |
Gillum, DM | 1 |
Alfrey, AC | 1 |
Harris, DC | 1 |
Hammond, WS | 1 |
Schrier, RW | 1 |
Houghton, BJ | 1 |
Brown, CL | 1 |
Thompson, E | 1 |
Dotchev, D | 1 |
Hungerland, H | 1 |
Liappis, N | 1 |
Oyanagi, K | 1 |
Krempien, B | 1 |
Ritz, E | 1 |
Schmidt, G | 1 |
Aleutskiĭ, NN | 1 |
Nifontova, VV | 1 |
Sul'din, AIa | 1 |
Gardner, B | 1 |
Gray, H | 1 |
Hedayati, H | 1 |
Pütter, J | 1 |
Daneels, R | 1 |
Chang, GN | 1 |
Fam, A | 1 |
Little, AH | 1 |
Malkin, A | 1 |
Walls, WD | 1 |
Losowsky, MS | 1 |
Simon, NM | 1 |
Bell, NH | 1 |
Del Greco, F | 1 |
Czerniak, Z | 2 |
Burzyński, S | 1 |
Young, GA | 1 |
Parsons, FM | 1 |
Minder, FC | 1 |
Dubach, UC | 1 |
Antener, I | 1 |
2 reviews available for glycine and Chronic Kidney Failure
Article | Year |
---|---|
Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
Topics: Adult; Amino Acid Substitution; Arginine; Circadian Rhythm; Combined Modality Therapy; DNA Mutationa | 2013 |
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.
Topics: Anemia; Animals; Barbiturates; Blood Pressure; Disease Models, Animal; Drug Design; Drug Interaction | 2017 |
9 trials available for glycine and Chronic Kidney Failure
Article | Year |
---|---|
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).
Topics: Anemia; Glycine; Hematinics; Hemoglobins; Humans; Isoquinolines; Kidney Failure, Chronic; Renal Dial | 2021 |
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for Treatment of Anemia in Chronic Kidney Disease: A Placebo-Controlled Study of Pharmacokinetic and Pharmacodynamic Profiles in Hemodialysis Patients.
Topics: Administration, Oral; Adult; Aged; Anemia; Area Under Curve; Dose-Response Relationship, Drug; Doubl | 2020 |
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
Topics: Anemia; Epoetin Alfa; Erythropoietin; Glycine; Hematinics; Hemoglobins; Humans; Isoquinolines; Kidne | 2021 |
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Epoetin Alfa; Female; Glycine; Hematinics; Humans; Isoquinol | 2016 |
A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Blood Proteins; Boron Compounds; Drug | 2016 |
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Topics: Cysteine; Genotype; Glycine; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Me | 2003 |
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Area Under Curve; Azetidines; Benzylamines; Cross | 2003 |
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Azetidines; Benzylamines; Chronic Disease; Dalteparin; G | 2005 |
Abnormal glycine betaine content of the blood and urine of diabetic and renal patients.
Topics: Adult; Albuminuria; Betaine; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus; Fe | 1994 |
42 other studies available for glycine and Chronic Kidney Failure
Article | Year |
---|---|
Roxadustat on anti-erythropoietin antibody-related pure red cell aplasia in the patient with end-stage renal disease.
Topics: Adult; Erythropoietin; Female; Glycine; Humans; Isoquinolines; Kidney Failure, Chronic; Recombinant | 2021 |
Emerging treatments for anemia in patients with CKD and ESRD.
Topics: Anemia, Iron-Deficiency; Drugs, Investigational; Glycine; Humans; Hypoxia-Inducible Factor-Proline D | 2017 |
Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl.
Topics: Adult; Aged; Alleles; Arginine; Base Sequence; Calcium; Cinacalcet; Clinical Trials as Topic; DNA; E | 2005 |
Vascular effects of the human extracellular superoxide dismutase R213G variant.
Topics: Amino Acid Substitution; Animals; Arginine; Diabetic Nephropathies; Disease Models, Animal; Gene Tra | 2005 |
Endogenous ligand(s) decrease drug--protein binding in uremic sera: a fluorescence probe study.
Topics: Adult; Clofibrate; Clofibric Acid; Dansyl Compounds; Female; Fluorescent Dyes; Glycine; Humans; Kidn | 1983 |
Small intestinal dipeptidases and disaccharidases in experimental uremia in rats.
Topics: alpha-Glucosidases; Animals; beta-Galactosidase; Dipeptidases; Disaccharidases; Glycine; Intestinal | 1980 |
Small intestinal absorption of glycine and glycyl-glycine in patients with chronic renal failure.
Topics: Adult; Aged; Amines; Amino Acids; Dipeptides; Female; Glycine; Glycylglycine; Humans; Intestinal Abs | 1983 |
Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.
Topics: Benzoates; Benzoic Acid; Female; Glomerular Filtration Rate; Glycine; Hippurates; Humans; Kidney Fai | 1982 |
The lack of effect of guanidinoacetic acid on in vitro osmotic fragility of erythrocytes.
Topics: Glycine; Humans; Kidney Failure, Chronic; Osmotic Fragility; Renal Dialysis | 1982 |
Metabolic pathway of guanidino compounds in chronic renal failure.
Topics: Animals; Arginine; Blood Urea Nitrogen; Creatinine; Glycine; Guanidines; Kidney Failure, Chronic; Ma | 1982 |
Guanidino compounds and hemodialysis.
Topics: Acute Kidney Injury; Blood Urea Nitrogen; Creatinine; Glycine; Guanidines; Hepatic Encephalopathy; H | 1982 |
Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Topics: Animals; Arginine; Creatine; Glycine; Guanidines; Homoarginine; Kidney; Kidney Failure, Chronic; Mal | 1995 |
Disposal of exogenous amino acids by muscle in patients with chronic renal failure.
Topics: Adult; Amino Acids; Analysis of Variance; Female; Glycine; Histidine; Humans; Insulin; Kidney Failur | 1995 |
Cerebral metabolite patterns in dialysis patients: evaluation with H-1 MR spectroscopy.
Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Glycine; Humans; Inositol; Kidney Failure, C | 1995 |
Study on impaired metabolism of guanidinoacetic acid in chronic renal failure rabbits with special reference to impaired conversion of arginine to guanidinoacetic acid.
Topics: Animals; Arginine; Blood Urea Nitrogen; Carbon Radioisotopes; Glycine; Kidney Failure, Chronic; Rabb | 1993 |
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.
Topics: Adult; Age of Onset; Amino Acid Sequence; Base Sequence; Codon; Collagen; DNA Primers; DNA Transposa | 1996 |
Which amino-acids do serum and hemofiltrate of critically ill patients with acute renal failure contain?
Topics: Alanine; Amino Acids; Asparagine; Citrulline; Cystathionine; Ethanolamines; Extracorporeal Circulati | 1997 |
Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
Topics: Adrenomedullin; Adult; Aged; Atrial Natriuretic Factor; Calcitonin Gene-Related Peptide; Creatinine; | 1999 |
Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Topics: Acute Kidney Injury; Animals; Arginine; Creatine; Creatinine; Glycine; Guanidines; Homoarginine; Kid | 2001 |
Metabolic studies with keto acid diets.
Topics: Aged; Female; Glycine; Humans; Keto Acids; Kidney Failure, Chronic; Male; Middle Aged; Nitrogen; Ure | 1978 |
[Gastroenterologic diseases and their relationship to the urogenital system].
Topics: Amyloidosis; Bile Acids and Salts; Celiac Disease; Cholelithiasis; Cholestyramine Resin; Colitis, Ul | 1978 |
Pharmacokinetics and metabolism of lidocaine in patients with renal failure.
Topics: Computers; Ethylamines; Glycine; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Lidocaine; Xy | 1975 |
Studies on the precursor of methylguanidine in rats with renal failure.
Topics: Animals; Arginine; Creatinine; Glycine; Kidney; Kidney Failure, Chronic; Liver; Male; Methylguanidin | 1991 |
Aminoaciduria as a marker of acute renal transplant rejection--a patient study.
Topics: Adolescent; Alanine; Amino Acids; Child; Child, Preschool; Creatinine; Female; Glycine; Graft Reject | 1991 |
Utilization of tyrosine dipeptides and acetyltyrosine in normal and uremic humans.
Topics: Adult; Creatinine; Dipeptides; Female; Glycine; Half-Life; Humans; Kidney Failure, Chronic; Male; Me | 1991 |
[Whole-body protein turnover and plasma glycine kinetics in chronic renal failure before and after treatment with essential amino acids].
Topics: Adult; Amino Acids, Essential; Female; Glycine; Humans; Kidney Failure, Chronic; Kinetics; Male; Mid | 1987 |
15N tracer kinetic investigations on the protein metabolism in a child with chronic renal failure fed a protein-restricted diet.
Topics: Adolescent; Amino Acids, Essential; Dietary Proteins; Female; Glycine; Humans; Kidney Failure, Chron | 1988 |
Phosphate depletion arrests progression of chronic renal failure independent of protein intake.
Topics: Aluminum Hydroxide; Animals; Blood Pressure; Blood Urea Nitrogen; Calcium; Cholesterol; Creatinine; | 1986 |
Synthesis of phenylalanine and valine by healthy and uraemic men.
Topics: Adult; Amino Acids; Ammonium Chloride; Carbon; Diet; Female; Glycine; Humans; Keto Acids; Kidney; Ki | 1971 |
[Hyperiminoaciduria and disaminoaciduria in endemic (Balkan-)nephropathy (author's transl)].
Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Thin Layer; Chronic Disease; Creatinine; Female; | 1974 |
[Experimental autoradiographic investigations of the collagen metabolism of bone in uremia].
Topics: Acute Kidney Injury; Animals; Autoradiography; Bone and Bones; Collagen; Glycine; Kidney Failure, Ch | 1972 |
[The therapeutic effect of morphocycline, glycocycline and reverin in experimental nephritis both complicated and not complicated by infection].
Topics: Animals; Basement Membrane; Female; Glycine; Immune Sera; Kidney Failure, Chronic; Kidney Glomerulus | 1974 |
Bone collagenase in osteolytic stress of rats and humans.
Topics: Animals; Biological Assay; Bone Resorption; Breast Neoplasms; Carbon Isotopes; Glycine; Humans; Hype | 1970 |
[Qualitative chromatographic determination of the conjugates of salicylic and salicyluric acids in blood plasma and urine].
Topics: Aspirin; Chromatography, Thin Layer; Glucuronates; Glycine; Humans; Hydrolysis; Kidney Failure, Chro | 1974 |
The uptake of glycine-14C into the adenine and guanine of DNA and insoluble RNA of human leucocytes.
Topics: Adenine; Autoanalysis; Carbon Radioisotopes; Chromatography, Paper; DNA; Female; Glycine; Gout; Guan | 1974 |
Abnormalities of fibrin stabilization in liver and kidney disease: a comparison of two different methods.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Chronic Disease; Factor XIII; Female; Glycine; Hemorrh | 1969 |
Iminoacidopathy in renal failure.
Topics: Calcium; Glycine; Humans; Hydroxyproline; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Fa | 1970 |
N-substituted amino acids in serum of patients with chronic renal insufficiency.
Topics: Alanine; Amino Acids; Aspartic Acid; Cystine; Glutamates; Glycine; Humans; Kidney Failure, Chronic; | 1970 |
[Free, N-substituted and peptide amino acids in urine of patients with chronic renal insufficiency].
Topics: Adult; Aged; Amino Acid Metabolism, Inborn Errors; Amino Acids; Aspartic Acid; Female; Glycine; Huma | 1970 |
Bound amino acids in serum of patients with chronic renal insufficiency.
Topics: Adult; Aged; Amino Acids; Analysis of Variance; Aspartic Acid; Chromatography, Paper; Female; Glomer | 1969 |
The effect of peritoneal dialysis upon the amino acids and other nitrogenous compounds in the blood and dialysates from patients with renal failure.
Topics: Adult; Amino Acids; Aspartic Acid; Butyrates; Creatinine; Diet Therapy; Female; Glutamates; Glycine; | 1969 |
[Hereditary nephropathy and hardness of hearing (with metabolic disorders of amino acids and fats in a family from Switzerland)].
Topics: Adolescent; Adult; Aged; Amino Acid Metabolism, Inborn Errors; Child; Child, Preschool; Deafness; Dw | 1965 |